GOSS NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Gossamer Bio Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 0.17 USD
24.6% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -78.2% below the Trend Line and sits at 1.5% of its 52-week range. The latest completed week returned 24.6%, after a -2.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 52/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: earnings are due in 2d.

Setup score 32 out of 100
Latest Close 0.17 USD 31 Jul 2026
1W Return 24.6% latest completed week
4W Return -2.1% short-term follow-through
12W Return -48.2% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 5.4x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 24.6% Latest completed week; four-week move -2.1%. Indicator stack 26/59 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 52/100 conviction; expected move 265.5%. News sentiment 52/100 42 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -78.2% below the Trend Line and sits at 1.5% of its 52-week range. The latest completed week returned 24.6%, after a -2.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 5.4x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0212-week average 0.01

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.02Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.1% over four weeks, -48.2% over 12 weeks, and -91.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W24.6%
4W-2.1%
12W-48.2%
26W-92.6%
52W-91.5%
Active trend streak0 weeks
Active weeks in one year25
Trend breadth48.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.41Latest activity-pressure read.
Pressure change21.0%Four-week change in activity pressure.
Leadership-90.74Latest relative-leadership reading.
RS change0.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 76% Model confidence 73%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength80/100Blend of value, momentum, and quality. Underlying universe rank 21; rank 1 is best.
Value65/100Relative valuation strength. Underlying universe rank 36; rank 1 is best.
Quality63/100Profitability and accounting quality. Underlying universe rank 38; rank 1 is best.
Momentum65/100Medium-term price momentum. Underlying universe rank 36; rank 1 is best.
Growth65/100Revenue and earnings growth. Underlying universe rank 36; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.2x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-74.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
99.6%
Gross profit retained from each unit of revenue.
Operating margin
-305.2%
Operating profit retained from revenue.
Free-cash-flow margin
-306.5%
Free cash flow generated from revenue.
Return on invested capital
-30121.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-55.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-208.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
0/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

GOSS shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.08, expected move of 265.5%, and Sharemaestro trend signal inactive.

Conviction52/100
Expected move265.5%
Put/call volume0.08
Pressure96
Speculation8
Volatility96
Trend agreement0
Open options detail
Insider activity6 / 0

6 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment52/100

Weighted news tone is neutral across 42 relevant articles.

9 positive · 28 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move265.5%Nearest-chain priced movement where available.
52-week drawdown-95.6%Distance below the 52-week high.
13-week volatility15.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+24.6%Week of 31 Jul.
Worst week-80.1%Week of 27 Feb.
Latest week+24.6%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains5
Flat weeks0
Modest losses3
Sharp losses11
Recent vol15.9%13-week weekly-return volatility.
Base vol16.6%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew10.0% / -12.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape35/100

Trend, activity pressure, participation, and risk combine to a 35/100 tape read.

 Indicator analysis23/100

Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.

Activity pressure 0.02; No reversal markers Factors68/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 44; Small Cap Core rank 44 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options35/100

GOSS shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.08, expected move of 265.5%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 265.5% Sentiment52/100

Weighted news tone is neutral across 42 relevant articles.

Gossamer Bio Company Profile & Introduction Insiders6 / 0

6 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings2d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20260.17 USD24.6%0.78 USD1.20 USD0.41-90.74654.9MOff
24 Jul 20260.14 USD-20.0%0.87 USD1.20 USD0.31-92.7196.0MOff
17 Jul 20260.17 USD0.2%0.97 USD1.21 USD0.37-91.22123.1MOff
10 Jul 20260.17 USD-2.0%1.08 USD1.22 USD0.32-91.7670.3MOff
3 Jul 20260.17 USD10.3%1.20 USD1.23 USD0.34-91.5754.7MOff
26 Jun 20260.16 USD-6.5%1.30 USD1.23 USD0.34-92.3987.2MOff
19 Jun 20260.17 USD3.8%1.41 USD1.24 USD0.19-92.3371.5MOff
12 Jun 20260.16 USD-7.5%1.50 USD1.25 USD0.04-92.53102.2MOff
5 Jun 20260.17 USD-24.2%1.59 USD1.26 USD-0.24-91.8565.9MOff
29 May 20260.23 USD9.9%1.66 USD1.26 USD-0.58-89.8854.4MOff
22 May 20260.21 USD-38.2%1.73 USD1.27 USD-0.82-90.63149.1MOff
15 May 20260.34 USD4.0%1.81 USD1.28 USD-1.05-84.8517.3MOff
8 May 20260.33 USD-11.6%1.87 USD1.28 USD-1.17-85.6120.1MOff
1 May 20260.37 USD2.0%1.94 USD1.29 USD-1.25-83.0225.2MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.